+2.13%
Today
Loading 1D prices…
Company profile
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Monrovia, CA, United States
Employees
32
Fiscal year end
1231
CIK
2010788
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| IMAImageneBio Inc. Common Stock | $57.8M | $800K | -5668.63% | -$9.64 | +1.50% | Hold |
| INKTMiNK Therapeutics Inc. Common Stock | $61.2M | $0.00 | — | -$2.93 | -1.07% | Buy |
| INMBINmune Bio Inc. Common stock | $61.6M | $50K | -92000.00% | -$1.86 | -3.90% | Buy |
| ELOXEloxx Pharmaceuticals Inc. Common Stock | $54.1M | $0.00 | — | -$5.34 | -3.26% | Buy |
| LONALeonaBio Inc. Common Stock | $65.2M | $0.00 | — | -$24.70 | +0.87% | Buy |